#United States #AI Healthcare #Cambridge, Massachusetts #OpenEvidence #Medical Search

OpenEvidence Secures Landmark Funding

OpenEvidence, a groundbreaking application shaping the future of medical decision-making, has announced a successful Series B funding round of $210 million, elevating its valuation to an astounding $3.5 billion. The funding round was propelled by the investment powerhouses Google Ventures and Kleiner Perkins, with follow-up support from Sequoia Capital and other prominent investors standing behind its mission.

Transforming Clinical Decision-Making

The growth of OpenEvidence reflects an urgent need for innovative solutions in healthcare. Designed specifically for verified U.S. clinicians, this application enables healthcare providers to make high-stakes clinical decisions with ease and speed. In fact, more than 40% of U.S. physicians log into OpenEvidence daily, underscoring its integral role in modern clinical practice.

In July 2024, OpenEvidence supported approximately 358,000 consultations in a single month. One year later, that figure has skyrocketed to an impressive 8.5 million consultations per month. This 2000% increase year-over-year highlights the platform's essentiality, especially as challenges like clinician burnout and a looming physician shortfall become more pronounced.

Breaking Information Overload

Faced with an overwhelming flood of medical research, clinicians often struggle to find relevant information quickly. The landscape of medical databases is fraught with complexity—where traditional databases are fragmented and slower, OpenEvidence offers a cohesive solution. Through key partnerships with influential medical publications, including the American Medical Association and The New England Journal of Medicine, it enables clinicians to access verified, evidence-based answers in moments.

The application's HIPAA compliance ensures that it responsibly handles sensitive patient data while providing swift access to the latest research. Users can input specific clinical questions or details about patient cases and receive accurate, evidence-grounded answers, equipping them to make informed choices at the point of care.

DeepConsult: AI-Powered Insights

The recent funding announcement comes alongside the launch of OpenEvidence DeepConsult™, an advanced AI agent specifically designed to support physicians. This pioneering tool allows clinicians to pose complex questions and receive comprehensive reports crafted from extensive literature research. DeepConsult operates around the clock, offering a level of service that promises to revolutionize routine medical queries—once a physician provides input, they can receive detailed analyses by the time they return from a break.

Notably, each DeepConsult task requires significantly more processing power than a standard search, yet OpenEvidence remains committed to providing it free of charge to verified U.S. clinicians. This represents a substantial investment in the healthcare system, aiming to ensure that medical professionals are not only informed but can also keep pace with an ever-growing body of research.

Looking Ahead with Visionaries

OpenEvidence's founder, Daniel Nadler, has received recognition for his innovation, making the TIME100 Health list in 2025. His vision goes beyond mere technical advancement; he believes in using AI to alleviate pressures on healthcare providers while simultaneously enhancing patient care. The backing from seasoned investors like Sangeen Zeb from Google Ventures and John Doerr of Kleiner Perkins solidifies the platform's potential to transform the healthcare landscape.

With over 65,000 new U.S. clinician registrations each month, OpenEvidence is on a meteoric rise. More than 100 million Americans will be treated by physicians using OpenEvidence this year, showcasing its undeniable impact on patient care and informed decision-making. As the healthcare sector continues to evolve, tools like OpenEvidence offer a glimmer of hope and innovation in a traditionally rigid system.

Conclusion

As OpenEvidence refines its offerings and expands its strategic partnerships to enhance medical knowledge accessibility, it stands as a leading force in reshaping how clinicians interact with information. The journey of making clinical decision-making smarter, faster, and more reliable is just beginning, but OpenEvidence undoubtedly leads the charge—equipping healthcare professionals with the tools they need to improve patient outcomes and save lives.